Increasing access to erectile dysfunction treatment via pharmacies to improve healthcare provider visits and quality of life: Results from a prospective real‐world observational study in the United Kingdom

OBJECTIVES: The Medicines and Healthcare Products Regulatory Agency in the United Kingdom (UK) formally reclassified sildenafil citrate 50 mg tablets as a pharmacy medicine (sildenafil‐P) in 2017 for adult men with erectile dysfunction (ED). A 1‐year prospective real‐world observational study was co...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Lauren J., Maguire, Terence A., Maculaitis, Martine C., Emir, Birol, Li, Vicky W., Jeffress, Mara, Li, Jim Z., Zou, Kelly H., Donde, Shaantanu S., Taylor, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047876/
https://www.ncbi.nlm.nih.gov/pubmed/33220087
http://dx.doi.org/10.1111/ijcp.13849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047876/
https://www.ncbi.nlm.nih.gov/pubmed/33220087
http://dx.doi.org/10.1111/ijcp.13849

Ejemplares similares